Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
GGT measurement is principally used to diagnose and monitor
hepatobiliary disease. It is currently the most sensitive enzymatic
indicator of liver disease. GGT in serum can be used to ascertain
whether observed elevations of ALP are due to skeletal disease
(normal GGT) or reflect the presence of hepatolbiliary disease
(elevated GGT). GGT is also used as a screening test for occult
alcholism.
Gamma-glutamyltransferase (GGT) is primarily present in kidney,
liver and pancreatic cells. Small amounts are present in other tissues.
Even though renal tissue has the highest level of GGT, the enzyme
present in the serum appears to originate primarily from the hepatobiliary
system, and GGT activity is elevated in any and all forms of liver
disease. It is highest in cases of intra- or posthepatic biliary obstruction,
reaching levels some five to thirty times normal. It is more sensitive
than ALP, NTP, leucine aminopeptidase, AST and ALT in detecting
obstructive jaundice, cholangitis and cholecystitis; its rise occurs
earlier than these other enzymes and persists longer. Only
modest elevations (two to five times normal) occur in infectious hepatitis,
and in this condition GGT determinations are less useful diagnostically
than are measurements of the transaminases. High elevations of GGT
are also observed in patients with either primary or secondary (metastatic)
neoplasms. Elevated levels of GGT are noted not only in the sera of
patients with alcoholic cirrhosis but also in the majority of sera from
persons who are heavy drinkers. Studies have emphasized the value
of serum GGT levels in detecting alcohol-induced liver disease.
Elevated serum values are also seen in patients receiving drugs such
as phenytoin and phenobarbital, and this is thought to reflect induction
of new enzyme activity.
Males
0-11 months: not established
1-6 years: 7-19 U/L
7-9 years: 9-22 U/L
10-13 years: 9-24 U/L
14-15 years: 9-26 U/L
16-17 years: 9-27 U/L
18-35 years: 9-31 U/L
36-40 years: 8-35 U/L
41-45 years: 9-37 U/L
46-50 years: 10-39 U/L
51-54 years: 10-42 U/L
55 years: 11-45 U/L
> or = 56 years: 12-48 U/L
Females
0-11 months: not established
> or = 1 year: 6-29 U/L
An elevation of GGT activity is seen in any and all forms of liver
disease, although the highest elevations are seen in intra- or
posthepatic biliary obstruction. Elevated values can also indicate
alcoholic cirrhosis or individuals who are heavy drinkers. Normal
values are observed in various muscle disease and in renal failure.
Normal values are also seen in cases of skeletal disease, children
older than one year and in healthy pregnant women--conditions in
which ALP is elevated. Thus, measurement of GGT in serum can be
used to ascertain whether observed elevations of ALP are due to
skeletal disease or reflect the presence of hepatobiliary disease.
GGT activity is inducible by drugs such as phenytoin and
phenobarbital, and therefore, elevations should not be considered
indicative of liver disease until drug use is ruled out. Elevations are
also seen after ingestion of alcoholic beverages.
Tietz Textbook of Clinical Chemistry, Edited by CA Burtis, ER Ashwood.
WB Saunders Company, Philadelphia, 1999